Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Jackson, E K; Gillespie, D G; Dubey, R K (2011). 2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors. Journal of Pharmacology and Experimental Therapeutics, 337(2):444-450.

Verrier, J D; Exo, J L; Jackson, T C; Ren, J; Gillespie, D G; Dubey, R K; Kochanek, P M; Jackson, E K (2011). Expression of the 2′,3′-cAMP-adenosine pathway in astrocytes and microglia. Journal of Neurochemistry, 118(6):979-987.

Cheng, D; Zhu, X; Barchiesi, F; Gillespie, D G; Dubey, R K; Jackson, E K (2011). Receptor for activated protein kinase C1 regulates cell proliferation by modulating calcium signaling. Hypertension, 58(4):689-695.

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Dubey, R K; Jackson, E K; Gillespie, D G; Zacharia, L C; Imthurn, B; Rosselli, M (2010). Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells. Journal of Clinical Endocrinology and Metabolism, 95(9):E9-E17.

Dubey, R K; Rosselli, M; Gillespie, D G; Mi, Z; Jackson, E K (2010). Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth. Journal of Pharmacology and Experimental Therapeutics, 333(3):808-815.

Jackson, E K; Ren, J; Gillespie, D G; Dubey, R K (2010). Extracellular 2',3'-cyclic adenosine 5'-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension, 1(56):151-158.

Baruscotti, I; Gillespie, D G; Jackson, E K; Imthurn, B (2008). Estradiol induces mitogenesis in human progenitor endothelial cells (PECs) by upregulating cyclins and downregulating p21. In: 7th Day of Clinical Research, University Hospital Zurich, 27 March 2008 - 29 March 2008.

Dubey, R K; Jackson, E K; Gillespie, D G; Zacharia, L C; Wunder, D; Imthurn, B; Rosselli, M (2008). Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism. Hypertension, 51(4):1197-1202.

Barchiesi, F; Jackson, E K; Fingerle, J; Gillespie, D G; Odermatt, B; Dubey, R K (2006). 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circulation Research, 99(3):266-274.

This list was generated on Fri Apr 19 04:41:23 2019 CEST.